Multi-modal disease segmentation is essential for the diagnosis and treatment of patients. Advanced algorithms have been proposed, however, two challenging issues remain unsolved, i.e., lacked knowledge share and limited modal relation. To this end, we develop a novel framework for multi-modal disease segmentation. It is based on improved continual learning and adaptive decision fusion. Specifically, continual learning with -means sampling is developed to highlight knowledge share from multi-modal medical images. In addition, we propose an adaptive decision fusion technique that uses the Naive Bayesian algorithm to improve the relationship between different modalities. To evaluate our proposed model, we chose two typical tasks, i.e., myocardial pathology segmentation and brain tumor segmentation. Four benchmark datasets, i.e., myocardial pathology segmentation challenge 2020 (MyoPS 2020), brain tumor segmentation challenge 2018 (BraTS 2018), BraTS 2019, and BraTS 2020, are utilized to train and test our framework. Both the qualitative and quantitative results demonstrate that our proposed model is effective and has advantages over peer state-of-the-art (SOTA) methods.
Multi-modal disease segmentation with continual learning and adaptive decision fusion
Thakur, DipanwitaValidation
;
2025-01-01
Abstract
Multi-modal disease segmentation is essential for the diagnosis and treatment of patients. Advanced algorithms have been proposed, however, two challenging issues remain unsolved, i.e., lacked knowledge share and limited modal relation. To this end, we develop a novel framework for multi-modal disease segmentation. It is based on improved continual learning and adaptive decision fusion. Specifically, continual learning with -means sampling is developed to highlight knowledge share from multi-modal medical images. In addition, we propose an adaptive decision fusion technique that uses the Naive Bayesian algorithm to improve the relationship between different modalities. To evaluate our proposed model, we chose two typical tasks, i.e., myocardial pathology segmentation and brain tumor segmentation. Four benchmark datasets, i.e., myocardial pathology segmentation challenge 2020 (MyoPS 2020), brain tumor segmentation challenge 2018 (BraTS 2018), BraTS 2019, and BraTS 2020, are utilized to train and test our framework. Both the qualitative and quantitative results demonstrate that our proposed model is effective and has advantages over peer state-of-the-art (SOTA) methods.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


